MARCELLI PASCAL-RODRIGUEZ: Open Payments
NPI 1518480045 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 22 payments from 8 companies in 2025. Trend: 2023 $929 · 2024 $451 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $177 |
| Otsuka America Pharmaceutical, Inc. | 3 | $91 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $18 |
| TMS NeuroHealth Centers Inc. | 1 | $9 |
Products named: VRAYLAR, REXULTI, NUEDEXTA, Qelbree, COBENFY, CAPLYTA, ARISTADA, TMS NeuroHealth Centers Inc..
Industry payments across VA — which companies pay providers there.
